New Drug Target for Neurodegenerative Disease?
Researchers in California may have discovered new drug targets to treat an incurable hereditary disease that leads to loss of motor coordination, dementia and death.
feature2
Researchers Develop Implantable Glucose Monitoring Device for Diabetics
Researchers at the University of California San Diego and GlySens Inc. are developing an implantable wireless sensor to continuously monitor blood sugar in diabetes patients, Reuters reports.
Encouraging Fragile X Data for Seaside Therapeutics
Seaside Therapeutics reported encouraging results from the largest randomized study conducted to date in patients with Fragile X syndrome.
New Imaging Technique May Provide a Closer Look at Cell Death
The information could allow researchers to observe cellular changes as a patient undergoes cancer treatment, and could aid in the development of new molecular therapeutics for diseases such as cancer.
Nektar Announces Positive Data on Ovarian Cancer Drug
An experimental drug from Nektar Therapeutics was able to shrink tumors and reduce a cancer biomarker in women with advanced ovarian cancer in a mid-stage study.
Celiac Disease: A Significant, Unmet Clinical Need
A disease that affects a significant number of Americans, that requires extensive and often frustrating lifestyle modifications, and that has no approved pharmaceutical treatment: It’s an enticing opportunity for drug companies.
Cholesterol Drugs May Slow Diabetic Vision Loss, Study Finds
A large-scale study funded by the National Institutes of Health found that both blood sugar control and a combination of cholesterol-lowering lipid drugs were effective in slowing the progression of diabetic retinopathy.
Here Come the Robots
Surgical robots were once considered a fantastical invention of sci-fi authors. But the future, as they say, is now.
NeuroPace Files with FDA for Epilepsy Device
NeuroPace, a company focused on implantable devices for the treatment of brain disorders, announced Thursday that it has filed for Pre-Market Approval with the U.S. Food and Drug Administration for its investigational device for epilepsy patients.
FDA Approves Implantable Telescope for the Eye
The U.S. Food and Drug Administration has approved the first implantable eye telescope to improve vision in patients with end-stage age-related macular degeneration.